ACCP Annual Meeting 2025

Richmond Pharmacology is glad to be attending the ACCP Annual Meeting 2025, hosted by the American College of Clinical Pharmacology, in Phoenix, Arizona, from 14^th–16^th September.

Representing Richmond at the ACCP Annual Meeting:

·        Dr Jörg Täubel, Chief Executive Officer

·        James Rickard,Chief Scientific Officer

Richmond looks forward to discussing our expertise in:

·        Translational and early-phase clinical pharmacology

·        First-in-human and adaptive trial designs

·        Innovative dose escalation and safety assessment

·        Pharmacokinetic/pharmacodynamic modelling

·        Regulatory collaboration and strategic guidance

If you’re attending ACCP 2025 and seeking a partner in clinical pharmacology and drug development, get in touch with us today to arrange a meeting: info@richmondpharmacology.com

Learn more: 2025 Annual Meeting

‍